BioLineRx Ltd. (BLRX) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for BioLineRx Ltd.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
20-F, BioLineRx Ltd.'s filing signal
continuing negative.
earningsVibe SuperAnalyst™ Verdict:
CONTINUING NEGATIVE
Signal Performance — Stock Price Since Filing
30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does BioLineRx Ltd. actually do?
Answer:
BioLineRx Ltd. is an Israeli biopharmaceutical company focused on developing therapies for oncology and rare diseases. Its lead product, APHEXDA(R) (motixafortide), is approved in the U.S. for stem cell mobilization in multiple myeloma patients and is being commercialized globally through licensing agreements with Ayrmid Pharma Ltd. and Auspex Bioscience (Gloria). The company is also advancing motixafortide for pancreatic cancer and other solid tumors. BioLineRx has a collaboration with Hemispherian AS for GLIX1, a novel small molecule targeting DNA damage response in glioblastoma and other cancers, with an IND application cleared by the FDA in August 2025. The company has refocused its operations on development activities in Israel following the out-licensing of its U.S. commercialization activities.
Question:
What are BioLineRx Ltd.'s revenue drivers?
Answer:
Revenue is primarily driven by upfront payments, milestone payments, and tiered royalties from out-licensing agreements for its lead product, motixafortide, with Ayrmid Pharma Ltd. and Auspex Bioscience (Gloria).
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required